Try our Advanced Search for more refined results
Searching dockets in Prinston Pharmaceutical Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability | New Jersey
Amended Complaint
AMENDED COMPLAINT against AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, JOHN DOE, HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC., SOLCO HEALTHCARE U.S., LLC, VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, WAL-MART, INC., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., filed by Anthony M DeFeo.(SUMMERLIN, AMANDA)
AMENDED COMPLAINT against CAMBER PHARMACEUTICALS, INC., DORIS HERSCHER, HETERO DRUGS, LTD., HETERO LABS, LTD., HETERO USA, INC., HUAHAI U.S. INC., JOHN DOE, MYLAN LABORATORIES LTD., MYLAN N.V., PRINSTON PHARMACEUTICAL INC., RITE AID CORP., SOLCO HEALTHCARE U.S., LLC, TORRENT PHARMA, INC., TORRENT PHARMACEUTICALS, LTD., VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, WALGREENS BOOTS ALLIANCE, ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., filed by Thomas L Herscher.(SUMMERLIN, AMANDA)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.